Objective
Patients with suspected acute aortic syndromes (AAS) often undergo CT with negative results. We sought clinical and diagnostic criteria to identify low risk patients, an initial step in developing a clinical decision rule.
Methods
We retrospectively identified all adults presenting to our Emergency Department (ED) from 1/1/2006- 8/1/2010 who underwent CT angiography for suspected AAS without prior trauma or AAS. 1,465 patients met inclusion criteria; a retrospective case-controlled review (ratio 1:4) was conducted. Cases were diagnosed with aortic dissection, intramural hematoma, penetrating atherosclerotic ulcer or ruptured aneurysm.
Results
2.7% (40/1,465) of patients who underwent CT had an AAS, 2 additional cases were diagnosed after admission [ED miss rate 5% (2/42)]. Patients with AAS were significantly older than controls (66 vs 59 yrs; p=.008). Risk factors included abnormal chest radiograph [sensitivity 79% (26/33), specificity 82% (113/137)] and acute chest pain [sensitivity 83% (29/35), specificity 71% (111/157)]. None of the 19 patients with resolved pain upon ED presentation had AAS. These data support a two-step rule: first screen for ongoing pain; if present, screen for acute chest pain or an abnormal chest radiograph. This approach achieves a 54% (84/155) reduction in CT usage with a sensitivity for AAS of 96% (95% CI: 89%-100%), negative predictive value of 99.8% (99.4%-100%) and a false negative rate of 1.7% (1/84).
Conclusions
Our results demonstrate a need to safely identify patients at low risk for AAS who can forgo CT. We developed a preliminary two-step clinical decision rule, which requires validation.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.